0001437749-14-021726.txt : 20141205 0001437749-14-021726.hdr.sgml : 20141205 20141205171434 ACCESSION NUMBER: 0001437749-14-021726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141204 FILED AS OF DATE: 20141205 DATE AS OF CHANGE: 20141205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAMVAKAS ELIAS CENTRAL INDEX KEY: 0001061865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 141270334 MAIL ADDRESS: STREET 1: 5280 SOLAR DRIVE STREET 2: SUITE 100 CITY: MISSISSAUGA STATE: A6 ZIP: L4W 5M8 4 1 rdgdoc.xml FORM 4 X0306 4 2014-12-04 0001299139 TearLab Corp TEAR 0001061865 VAMVAKAS ELIAS 9980 HUENNEKENS ST., STE 100 SAN DIEGO CA 92121 1 1 Chairman and CEO Common Stock 2014-12-04 4 P 0 50000 2.2428 A 320000 I See footnote Common Stock 1308139 I See footnote Common Stock 201404 D Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $2.18 to $2.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Shares held by Greybrook Corporation. The reporting person is an officer and a director of Greybrook Corporation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Shares held by Greybrook Capital, Inc. The reporting person is an officer and a director of Greybrook Capital Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ William Dumencu, as Attorney-in-Fact 2014-12-05